Evidence map›Paper›PMID 30723319›Full record

Trial reportEuropean journal of human genetics : EJHG2019

SCAPER localizes to primary cilia and its mutation affects cilia length, causing Bardet-Biedl syndrome.

Ohad Wormser, Libe Gradstein, Yuval Yogev, Yonatan Perez, Rotem Kadir, Inna Goliand, Yair Sadka, Saad El Riati, Hagit Flusser, Dikla Nachmias and 11 more

Open access · bronzeAbstract readClinical Trial
In one paragraph

Trial report in European journal of human genetics : EJHG, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
4.8field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 48 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Genes · 2024
    Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Limb girdle muscular disease caused byProceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  13. Article
  14. Bardet-Biedl Syndrome: Current Perspectives and Clinical Outlook.Therapeutics and clinical risk management · 2023
    Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 4 institutions in 1 country.

Ohad WormserThe Morris Kahn Laboratory of Human Genetics, National Institute for Biotechnology in the Negev and Faculty of Health Sciences, Ben-Gurion University of the Negev, 84105, Beer Sheva, Israel.ORCID 0000-0003-0007-1469
Libe GradsteinDepartment of Ophthalmology, Soroka Medical Center and Clalit Health Services, Faculty of Health Sciences, Ben-Gurion University, 84101, Beer Sheva, Israel.
Yuval YogevThe Morris Kahn Laboratory of Human Genetics, National Institute for Biotechnology in the Negev and Faculty of Health Sciences, Ben-Gurion University of the Negev, 84105, Beer Sheva, Israel.
Yonatan PerezThe Morris Kahn Laboratory of Human Genetics, National Institute for Biotechnology in the Negev and Faculty of Health Sciences, Ben-Gurion University of the Negev, 84105, Beer Sheva, Israel.
Rotem KadirThe Morris Kahn Laboratory of Human Genetics, National Institute for Biotechnology in the Negev and Faculty of Health Sciences, Ben-Gurion University of the Negev, 84105, Beer Sheva, Israel.
Inna GoliandDepartment of Life Sciences and National Institute for Biotechnology in the Negev, Ben Gurion University of the Negev, 84105, Beer Sheva, Israel.
Yair SadkaChild Developmental Center, Beer Sheva Mental Health Center, Ben-Gurion University of the Negev, 84101, Beer Sheva, Israel.
Saad El RiatiClalit Health Services, Southern district, P.O. Box 616, 30 Itzhak Rager Street, Beer sheva, Israel.
Hagit FlusserThe Zusman Institute for Child Development, Division of Pediatrics, Soroka Medical Center and Ben-Gurion University of the Negev, 84101, Beer Sheva, Israel.
Dikla NachmiasDepartment of Life Sciences and National Institute for Biotechnology in the Negev, Ben Gurion University of the Negev, 84105, Beer Sheva, Israel.
Ruth BirkDepartment of Nutrition, Faculty of Health Sciences, Ariel University, Ariel, Israel.
Muhamad IraqiThe Morris Kahn Laboratory of Human Genetics, National Institute for Biotechnology in the Negev and Faculty of Health Sciences, Ben-Gurion University of the Negev, 84105, Beer Sheva, Israel.
Einat KadarThe Morris Kahn Laboratory of Human Genetics, National Institute for Biotechnology in the Negev and Faculty of Health Sciences, Ben-Gurion University of the Negev, 84105, Beer Sheva, Israel.
Roni GatDepartment of Life Sciences and National Institute for Biotechnology in the Negev, Ben Gurion University of the Negev, 84105, Beer Sheva, Israel.
Max DrabkinThe Morris Kahn Laboratory of Human Genetics, National Institute for Biotechnology in the Negev and Faculty of Health Sciences, Ben-Gurion University of the Negev, 84105, Beer Sheva, Israel.
Daniel HalperinThe Morris Kahn Laboratory of Human Genetics, National Institute for Biotechnology in the Negev and Faculty of Health Sciences, Ben-Gurion University of the Negev, 84105, Beer Sheva, Israel.
Amir HorevDepartment of Dermatology and Venereology and Division of Pediatrics, Soroka Medical Center and Faculty of Health Sciences, Ben-Gurion University of the Negev, 84101, Beer Sheva, Israel.
Sara SivanThe Morris Kahn Laboratory of Human Genetics, National Institute for Biotechnology in the Negev and Faculty of Health Sciences, Ben-Gurion University of the Negev, 84105, Beer Sheva, Israel.
Uri AbduDepartment of Life Sciences, Ben-Gurion University, 84105, Beer Sheva, Israel.
Natalie EliaDepartment of Life Sciences and National Institute for Biotechnology in the Negev, Ben Gurion University of the Negev, 84105, Beer Sheva, Israel.
Ohad S BirkThe Morris Kahn Laboratory of Human Genetics, National Institute for Biotechnology in the Negev and Faculty of Health Sciences, Ben-Gurion University of the Negev, 84105, Beer Sheva, Israel. obirk@bgu.ac.il.
Ben-Gurion University of the Negev · ILAriel University · ILClalit Health Services · ILSoroka Medical Center · IL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Studies of ciliopathies have served in elucidating much of our knowledge of structure and function of primary cilia. We report humans with Bardet-Biedl syndrome who display intellectual disability, retinitis pigmentosa, obesity, short stature and brachydactyly, stemming from a homozyogous truncation mutation in SCAPER, a gene previously associated with mitotic progression. Our findings, based on linkage analysis and exome sequencing studies of two remotely related large consanguineous families, are in line with recent reports of SCAPER variants associated with intellectual disability and retinitis pigmentosa. Using immuno-fluorescence and live cell imaging in NIH/3T3 fibroblasts and SH-SY5Y neuroblastoma cell lines over-expressing SCAPER, we demonstrate that both wild type and mutant SCAPER are expressed in primary cilia and co-localize with tubulin, forming bundles of microtubules. While wild type SCAPER was rarely localized along the ciliary axoneme and basal body, the aberrant protein remained sequestered to the cilia, mostly at the ciliary tip. Notably, longer cilia were demonstrated both in human affected fibroblasts compared to controls, as well as in NIH/3T3 cells transfected with mutant versus wildtype SCAPER. As SCAPER expression is known to peak at late G1 and S phase, overlapping the timing of ciliary resorption, our data suggest a possible role of SCAPER in ciliary dynamics and disassembly, also affecting microtubule-related mitotic progression. Thus, we outline a human ciliopathy syndrome and demonstrate that it is caused by a mutation in SCAPER, affecting primary cilia.

Indexed as

Bardet-Biedl SyndromeCarrier ProteinsCiliaIntellectual DisabilityMutationRetinitis PigmentosaAnimalsFemaleHumansMaleMiceNIH 3T3 CellsCarrier ProteinsSCAPER protein, human

Identifiers

PMID30723319
PMCPMC6777442
OpenAlexW2914506937

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.